Codiak Bio Sciences
Biotechnology, 35 Cambridgepark Dr, Cambridge, , 2140, Massachusetts, United States, 51-200 Employees
Phone Number: 61********
Who is CODIAK BIOSCIENCES
About Codiak BioSciences Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potent...
Read More
-
Headquarters: 35 Cambridgepark Dr, Cambridge, Massachusetts, 2140, United States
-
Date Founded: 2015
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from CODIAK BIOSCIENCES
Codiak BioSciences Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Codiak BioSciences
Answer: Codiak BioSciences's headquarters are located at 35 Cambridgepark Dr, Cambridge, , 2140, Massachusetts, United States
Answer: Codiak BioSciences's phone number is 61********
Answer: Codiak BioSciences's official website is https://codiakbio.com
Answer: Codiak BioSciences's revenue is $25 Million to $50 Million
Answer: Codiak BioSciences's SIC: 2834
Answer: Codiak BioSciences's NAICS: 325412
Answer: Codiak BioSciences has 51-200 employees
Answer: Codiak BioSciences is in Biotechnology
Answer: Codiak BioSciences contact info: Phone number: 61******** Website: https://codiakbio.com
Answer: About Codiak BioSciences Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month